Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Healthcare Equipment & Supplies
|Small Cap
AMKAY
₹48.52
₹48.52
₹50.00
Data is not available
Markets Today
Historical Performance
As of 10-07-2026 21:39, Amkay Products Ltd. share price today is ₹0, with a change of ₹-47.30 (-100.00%) from the previous close of ₹47.3. The stock opened at ₹50 and traded between ₹48.52 and ₹50, with a total traded volume of 8000 shares. The company has a market capitalization of ₹40.9 Cr in the Healthcare sector. while its 52-week high and low are ₹81.99 and ₹39.22, respectively.
Amkay Products Ltd. valuation metrics include a P/E ratio of 17.7, and book value of ₹1.60. Profitability indicators show ROE of 8.76%.
Amkay Products Ltd. technical indicators include Day RSI at 35.46, Day MFI at 26.88, Day ADX at 17.8. Additional indicators include Commodity Channel Index (CCI) at -202.1 and Williams %R at -100. Momentum indicators show Day MACD at -2.08, Day MACD Signal Line at -1.41, DayATR at 2.63. Rate of Change indicators for Amkay Products Ltd. include ROC125 at -13.18 and ROC21 at -18.45.
Exponential moving averages include EMA5 at ₹51.6, EMA10 at ₹53.4, EMA12 at ₹53.8, EMA20 at ₹55.2, EMA26 at ₹55.9, EMA50 at ₹57.6, EMA100 at ₹57.9, EMA200 at ₹57.9. Simple moving averages include SMA5 at ₹52, SMA10 at ₹54.1, SMA20 at ₹56, SMA30 at ₹56.5, SMA50 at ₹58.6, SMA100 at ₹58.8, SMA150 at ₹57.2, SMA200 at ₹54.1.
Support levels for Amkay Products are placed at First Support ₹46.06, Second Support ₹44.83, Third Support ₹42.35. Resistance levels are seen at First Resistance ₹49.77, Second Resistance ₹52.25, Third Resistance ₹53.48. Amkay Products Ltd. shareholding pattern shows promoter holding at 73.44%, FII holding at 0%, DII holding at 0%, public holding at 26.56%.
Data not available for chart
Indicator |
|---|
| No Record Found |
₹48.52
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
Amkay Products Limited, with its corporate operations in Thane, functions as a healthcare company engaged in the manufacture, assembly, and marketing of medical devices, disposables, and other healthcare products. The company was incorporated in 2007. Amkay Products provides a comprehensive range of healthcare products including face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, blood pressure monitors, air beds, adult diapers, HIV kits, bio bags, suction machines, and apron gowns. The company serves medical professionals, retailers, hospitals, prestigious institutes, government bodies, pharmaceutical companies, distributors, and dealers.
Amkay Products share price on BSE signifies how market participants react to the company’s operational performance and the overall developments in the healthcare products sector. The company’s financial health depends on demand for medical devices and disposables from healthcare institutions, manufacturing efficiency, raw material costs, and the performance of its production operations. Amkay Products stock price is influenced by various factors such as earnings, fluctuations in raw material costs, regulatory changes in medical device manufacturing, and currency exchange rates. In the longer run, strategies such as expanding product portfolio, strengthening manufacturing capabilities, and entering new geographic markets affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company’s stock price movements.
Amkay Products live price provides real time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Amkay Products’ live price helps in observing short term price volatility and shows how a stock moves relative to the broader market indices. Furthermore, monitoring Amkay Products stock price movements helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance, and respond to news, quarterly results, or sector trends that may influence the company’s valuation and overall investment outlook.
Amkay Products Limited was originally incorporated as Amkay Products Private Limited on October 25, 2007 and subsequently converted to a public limited company. The company is headquartered in Thane, Maharashtra. The company is engaged in the manufacture, assembly, and marketing of a comprehensive portfolio of medical devices, disposables, and other healthcare products in India. Its product portfolio includes face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, blood pressure monitors, air beds, adult diapers, HIV kits, bio bags, suction machines, and apron gowns. The company serves medical professionals, retailers, hospitals, prestigious institutes, government bodies, pharmaceutical companies, distributors, and dealers. Corporate functions are managed from its administrative offices in Thane.
The medical devices and healthcare products industry is closely linked to demand from healthcare institutions and the growing healthcare needs of the population. Demand trends are influenced by healthcare spending, disease prevalence, demographic changes, and regulatory approvals. The industry is also affected by fluctuations in raw material prices, along with regulatory changes and currency exchange rates. Companies in the sector must manage manufacturing efficiency, quality standards, and regulatory compliance while maintaining operational flexibility. These factors collectively influence financial performance and investor perception of firms like Amkay Products.
Amkay Products Limited is listed on the Bombay Stock Exchange with the scrip code 544169. Amkay Products share price is actively traded on the exchange. The company’s market presence is within the micro-cap to small-cap segment of the market. Due to its size and sector focus, Amkay Products share price is generally tracked by investors interested in the healthcare products sector.
Amkay Products Limited is part of several broad-based and sector-specific stock market indices, reflecting its position as a healthcare products company in India. It finds representation in indices based on its market standing. Amkay Products stock price is monitored by investors tracking the healthcare and medical devices sectors. The company’s presence in these indices helps investors track the stock relative to other healthcare products companies. Amkay Products stock price is observed by market participants as an indicator of the performance of the healthcare products sector in India.
Amkay Products share price today on the BSE reflects its position as a healthcare products manufacturer in India. Its performance is qualitatively driven by factors such as manufacturing output, management of raw material costs, growth in customer base, and the ability to maintain quality standards. Investors compare Amkay Products movement with other healthcare products companies to assess relative strength.
These underlying factors become visible through real market movements across different time periods. Similar trends appear during earnings-driven price changes. Broader sector strength has also supported Amkay Products at certain times. Beyond operational and sector influences, corporate actions such as the company’s expansion into new product categories can significantly affect share price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short-term swings, even within a regulatory environment influenced by healthcare policies and demand patterns.
While short term movements respond to events and announcements, longer term valuation trends are better captured by Amkay Products annual high and low levels, offering context beyond daily or weekly changes. A notable peak indicates stronger healthcare demand and stable margins, whereas a significant low aligns with market corrections or sector volatility. These extremes reflect the impact of global economic conditions, raw material price fluctuations, and earnings visibility, providing a framework for understanding historical performance.
Amkay Products behaviour mirrors the trading patterns of a healthcare products company within India’s healthcare ecosystem. The company’s diversified product portfolio spanning medical devices, disposables, and healthcare consumables has shaped its price history. Over the past several years, Amkay Products has experienced periods of sharp gains followed by phases of consolidation. Amkay Products has shown certain volatility patterns reflecting the evolving nature of its business operations.
The company’s performance has closely tracked healthcare demand and medical device market cycles. Positive momentum appeared during periods of strong healthcare spending and favourable regulatory environment. However, periods of weak healthcare demand and intensified competition have led to consolidation in Amkay Products share price. Amkay Products faced selling pressure when raw material costs showed significant increases, reflecting structural challenges in managing input cost volatility in the healthcare products sector.
Despite macroeconomic disruptions, Amkay Products share price showed resilience during recovery phases. While the broader healthcare sector faced challenges, the company’s established product portfolio helped Amkay Products share price recover from lows. The company maintains a skilled workforce and continues to invest in expanding its manufacturing capabilities.
Amkay Products share price has declined for several recurring reasons. A drop in healthcare demand or lower product realizations directly impacts revenue visibility and leads to selling pressure. Changes in government policy on medical devices or healthcare regulations can also cause Amkay Products share price to fall. Moreover, increases in operational costs such as raw material prices without matching productivity gains squeeze margins, making Amkay Products share price less attractive. Periods of economic slowdown that affect healthcare spending raise concerns about demand pipelines, leading to price declines. Amkay Products share price is sensitive to currency exchange rate movements. Broader market sell offs in healthcare stocks also pull the price down, regardless of the company’s individual performance. Lower client retention or reduced order flow directly hurts revenue, resulting in a lower valuation.
Amkay Products has seen downward pressure when the company reported fluctuations in profit margins. Amkay Products movements often mirror broader healthcare sector trends. Amkay Products can be impacted by changes in raw material costs and client retention rates. Amkay Products has historically shown sensitivity to regulatory changes. Amkay Products may also be affected by the company’s ability to maintain its competitive edge in medical device manufacturing. Amkay Products stock price performance is closely watched by investors tracking the healthcare segment. Amkay Products has moved within a range reflecting the broader market correction in healthcare stocks.
Amkay Products Limited is a holding in healthcare and medical devices sector portfolios, offering exposure to medical devices, disposables, and healthcare products. Its presence in the healthcare products space underscores its importance in India’s healthcare sector. The company’s position as a manufacturer of healthcare products with expanding product capabilities makes it a consideration for long term allocations.
Amkay Products share price is influenced by the company’s ownership structure. The company’s equity is held by a broad mix of promoters, institutional investors, and retail investors, reflecting its standing in India’s healthcare sector. The company’s management includes Kashyap Pravin Mody as Managing Director. This investor base, with stable promoter participation, underscores the company’s role as a holding in both domestic and international portfolios concentrating on healthcare services.
Beyond fundamentals and ownership, Amkay Products share price is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on healthcare demand, raw material costs, and regulatory policy actions. Amkay Products stock price is available for trading on the major Indian exchange, allowing investors to take positions based on their outlook for the healthcare sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements.
Technical indicators provide additional insight into short term momentum shifts in Amkay Products share price. While these indicators are primarily used for near term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short term and weekly timeframe, the stock has exhibited price movements that correlate with broader healthcare sector trends. The company’s financial position reflects its operational performance in the manufacturing segment.
Overall, Amkay Products demonstrates a certain volatility profile compared to the broader market, with the stock generally considered to have exposure to sector specific factors such as healthcare demand, raw material costs, and currency fluctuations. Amkay Products share price is influenced by these factors. Amkay Products stock price reflects the company’s position in the healthcare products space.
Amkay Products Limited sector relevance stems from its presence in the medical devices and healthcare products industry, its position as a manufacturer of medical devices, disposables, and healthcare consumables, its portfolio covering face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, blood pressure monitors, air beds, and adult diapers, its service to medical professionals, retailers, hospitals, and government bodies, its manufacturing capabilities, and its status as a healthcare products company with diversified product offerings. Peer comparisons with companies in the healthcare and medical devices sector focus on manufacturing capacity, product portfolio, and operational scale rather than short term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of healthcare demand, medical device regulations, and raw material prices further highlights Amkay Products positioning within the broader healthcare products market.
Amkay Products market cap highlights its position as a player within the healthcare products sector. The company’s market capitalization has moved in line with investor perceptions of the company’s growth potential following its expansion into new product categories. From earlier periods through more recent times, the market cap showed trends as the company expanded its manufacturing capabilities. This pattern reflects investor confidence during favourable healthcare cycles, followed by consolidation during challenging periods impacted by macroeconomic headwinds. This movement mirrors the correction in Amkay Products share price from its highs to recent levels.
Amkay Products earnings trajectory demonstrates the impact of its operational execution in a competitive industry. In recent fiscal years, total income showed trends supported by the core healthcare products business. The company’s revenue from operations showed movements supported by demand across various product categories. Profit after tax demonstrated operational performance. However, the company has faced headwinds from fluctuating raw material prices, intensified competition, and regulatory changes. However, the company has expanded into new product categories and continues to invest in manufacturing capabilities. These developments illustrate the evolving nature of the healthcare products industry and the company’s position within this sector.
Amkay Products EPS provides insight into its operational performance and income generation from healthcare products activities. The company reported earnings that varied based on healthcare cycles and client spending patterns. The earnings per share has shown movements over time as the company navigated changing market conditions. The company has a face value per share. More recent quarterly performance suggests that EPS has shown movements as the company continues its manufacturing operations.
Amkay Products P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from healthcare products. The current valuation compared to industry averages indicates how the market assesses the company’s earnings potential. The company’s profit after tax has shown variations across recent fiscal periods based on operational performance. Overall, these changes highlight how market sentiment evolved alongside the company’s operational performance in a dynamic industry undergoing structural transformation. Amkay Products share price continues to be watched by market participants.
Amkay Products Limited, headquartered in Thane, operates as a healthcare company manufacturing medical devices, disposables, and healthcare products including face masks, nebulizers, and blood pressure monitors. The company, incorporated in 2007, serves clients across domestic markets. Amkay Products share price reflects market perceptions of the company’s manufacturing capabilities and product quality. Amkay Products stock price movements are influenced by healthcare demand, raw material costs, and regulatory changes, making it a consideration for investors tracking the healthcare products sector.
| Held By | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 73.4 | 73.4 | 73.4 | 73.4 | 73.4 | 73.4 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6 K | 6 K | 100.00% |
| Week | 6 K | 6 K | 100.00% |
| 1 Month | 0 | 0 | undefined% |
| 6 Month | 3.35 K | 3.63 K | 92.20% |
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹220.50 | ₹385 | ₹119.90 | ₹369.60 | ₹2.20 |
| % Change | 1.65% | 1.32% | 12.06% | 5.00% | -2.22% |
| Revenue TTM (₹ Cr) | ₹277.86 | - | - | - | - |
| Net Profit TTM (₹ Cr) | ₹28.98 | - | - | - | - |
| PE TTM | 41.10 | 29.60 | 8.00 | 23.90 | -23.40 |
| 1 Year Return | -50.26 | -6.99 | -52.08 | 214.54 | -53.61 |
| ROCE | 13.70 | 19.61 | 26.07 | 19.51 | - |
Tarsons Products Ltd.
₹ 302.95
+4.94%
Prevest Denpro Ltd.
₹ 380.15
-1.91%
Nureca Ltd.
₹ 234.05
+1.73%
Centenial Surgical Suture Ltd.
₹ 80.00
+3.84%
Shree Pacetronix Ltd.
₹ 152.00
+9.16%
Bilcare Ltd.
₹ 62.55
-3.05%
Emmessar Biotech & Nutrition Ltd.
₹ 24.61
+0.20%
Raaj Medisafe India Ltd.
₹ 71.00
+0.00%
By signing up I certify terms, conditions & privacy policy